Form D · Other Health Care
electroCore, Inc.
Rockaway, NJ · CIK 0001560258
Offering snapshot reported Apr 15, 2026 · SEC filing
- Reported sold
- $0 Indefinite offering
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 1, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 15, 2026 | Initial | $0 | No comparison | 0 | SEC filing |
| Oct 17, 2025 | Initial | $0 | No comparison | 0 | SEC filing |
| Oct 17, 2025 | Initial | $1,856,000 | No comparison | 3 | SEC filing |
| Sep 16, 2025 | Initial | $0 | No comparison | 0 | SEC filing |
| Nov 15, 2024 | Initial | $0 | No comparison | 0 | SEC filing |
| Aug 2, 2024 | Initial | $0 | No comparison | 0 | SEC filing |
| Jun 12, 2024 | Initial | $7,845,000 | No comparison | 13 | SEC filing |
| May 8, 2024 | Initial | $0 | No comparison | 0 | SEC filing |
| Aug 8, 2023 | Initial | $52,372 | No comparison | 7 | SEC filing |
| Aug 8, 2023 | Initial | $750,000 | No comparison | 6 | SEC filing |
| Oct 4, 2021 | Initial | $192,000 | No comparison | 0 | SEC filing |
| May 27, 2020 | Initial | $463,678 | No comparison | 1 | SEC filing |
| May 27, 2020 | Initial | $1,548,701 | No comparison | 1 | SEC filing |
| Apr 29, 2020 | Initial | $1,749,999 | No comparison | 3 | SEC filing |
| Dec 5, 2017 | Amendment | $70,890,210 | $34,890,210vs Sep 15, 2017 | 94 | SEC filing |
| Sep 15, 2017 | Amendment | $36,000,000 | $0vs Sep 7, 2017 | 31 | SEC filing |
| Sep 7, 2017 | Initial | $36,000,000 | No comparison | 31 | SEC filing |
| Aug 5, 2016 | Initial | $1,500,000 | No comparison | 1 | SEC filing |
| Nov 26, 2012 | Initial | $500,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-580593
As of April 1, 2026, Seth Abrams was granted an award of 30,000 RSUs. As of April 13, 2026, Michael Fox was granted an award of 70,000 RSUs. The grants were each made pursuant to an inducement grant under Nasdaq Listing Rule 5635(c)(4).
Restricted Stock Units ("RSUs")
Source: Form D, filed Apr 15, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Frank Amato | Director, Executive |
| Francis Amato | Executive |
| Michael G. Atieh | Director |
| Robert Bertolini | Director |
| Elena Bonfiglioli | Director |
| Nicholas Colucci | Director |
| Nick Colucci | Director |
| Peter Cuneo | Director |
| Gordon Donald | Director |
| Joseph P. Errico | Director |
| Thomas J. Errico | Director |
| Jp Errico | Director |
| J.P. Errico | Director, Executive |
| Michael Fox | Executive |
| John P. Gandolfo | Director |
| Daniel S. Goldberger | Director, Executive |
| Julie Ann Goldstein | Director |
| Joshua Lev | Executive |
| Steve Mendez | Executive |
| Trevor J. Moody | Director |
| Stephen Ondra | Director |
| Thomas M. Patton | Director |
| Brian Posner | Executive |
| David Rubin | Director |
| Brent Saunders | Director |
| Peter Staats | Director, Executive |
| Reese Terry | Director |
| Charles S. Theofilos | Director |
| Kathryn Theofilos | Director |
| James C. Theofilos | Director |
| Jim Tullis | Director |
| James L.L. Tullis | Director |
| Jeffrey Vinik | Director |
| Glenn Vraniak | Executive |
| Patricia Wilber | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
200 Forge Way Suite 205
Rockaway, NJ, 07866
Rockaway, NJ, 07866